PLEKHA5 has also been reported to be involved in the central nervous system homing mechanism in metastatic disease, and inhibition of PLEKHA5 may reduce the passage across the blood-brain barrier and reduce the proliferation and survival of melanoma cells in the brain and extrabrain regions (Jilaveanu et al., 2015). Here, PLEKHA5 is linked to metastatic neoplasm.